Seres Therapeutics (MCRB) Shares Pop to Session Highs
- Top 10 News for 10/24 - 10/28: AT&T (T), Time Warner Make it Official; Margins Hamper Apple's Q4; Mergers Aplenty
- Wall St. falls as FBI to review more Clinton emails
- Clinton email problem resurfaces as FBI announces review
- ExxonMobil (XOM) Tops Q3 EPS by 5c; CapEx Light of Views
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Seres Therapeutics (NASDAQ: MCRB) shares are popping to session highs. The stock is up around 2.2 percent Monday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NetSuite (N) volatility increases into Oracle’s (ORCL) $109 a share tender expiring
- Global funds raise cash to 16-month highs, cut bonds: Reuters poll
- Alphabet (GOOGL) volatility elevated at 108 as shares rally on Q3 video ads
Create E-mail Alert Related CategoriesTrader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!